Month: September 2015

September 25, 2015

BioWave Receives FDA Marketing Clearance for the new BioWaveHOME Neuromodulation Pain Therapy System

We are pleased to announce that BioWave Corporation has received FDA Marketing clearance for its new prescription neuromodulation pain therapy system called BioWaveHOME. BioWaveHOME is indicated for the treatment of acute, chronic or postoperative pain. The company anticipates that BioWaveHOME pain therapy systems will be available for sale starting in November 2015.